Correlation of Blood Serum Renalase and Microcirculation Obstruction in Patients with Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention
Recruiting now
Conditions studied: Acute Myocardial Infarction
In brief
This research will explore the association between blood serum renalase and microcirculation obstruction in patients with acute myocardial infarction (AMI) after primary percutaneous coronary intervention (PCI). The investigators aim to identify potential risk factors for microcirculation obstruction in AMI patients after PPCI.
Key facts
- Study ID
- NCT06669520
- Run by
- The Third Xiangya Hospital of Central South University
- People needed
- 200
- Starts
- 2024-08-01
- Expected to finish
- 2025-10-01
- Last updated by the study team
- 2024-11-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years;
- STEMI symptom onset time < 12 hours;
- STEMI symptom onset time 12-48 hours with persistent ischemic symptoms, hemodynamic instability, or life-threatening ventricular arrhythmias;
- High-risk NSTEMI;
- Emergency PCI;
- Voluntary informed consent.
You may not qualify if…
- Non-obstructive acute myocardial infarction;
- Severe chronic kidney disease (defined as estimated glomerular filtration rate < 20 mL/min per 1.73 m²);
- Life expectancy < 1 year;
- Pregnant or planning to become pregnant;
- Emergency PCI failure.
Where it is running
- The Third Xiangya Hospital of Central South University — Changsha, Hunan, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.